• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. Evaluation of Efficacy of Oral Terbinafine versus Itraconazole in Treatment of Dermatophytic Skin Infections at a Tertiary Care Hospital

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

Evaluation of Efficacy of Oral Terbinafine versus Itraconazole in Treatment of Dermatophytic Skin Infections at a Tertiary Care Hospital

    Author

    • Amit Singhal, Kumar Raja Madasu, Vinay Sharma, Anand
,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

Background: Superficial dermatophytosis affecting hair, skin and nail are common public health problem in India, because of the tropical climate with heat and humidity. The present study was conducted to assess efficacy of oral terbinafine versus itraconazole in treatment of dermatophytic infection of skin.
Materials & Methods: The patients were randomly divided into two groups to receive a daily dose of terbinafine 500 mg daily for 4 weeks (Group I) or 200 mg of itraconazole for 4 weeks daily (Group II). Patients were followed up after 2 weeks and 4 weeks of the study period. At each visit, clinical response was noted including pruritus, erythema, and scaling. All analysis was done SPSS version 21.0 (IBM Corp., Armonk, NY).
Results: A total of 100 patient were randomly divided into two groups to receive a daily dose of terbinafine 500 mg daily for 4 weeks (Group II) or 200 mg of itraconazole for 4 weeks daily (Group I). At baseline in group I erythema was severe in maximum patients, scaling, pruritus was moderate in maximum patients. At 2nd week in group I erythema, pruritus was moderate in maximum patients, scaling was mild in maximum patients. At 4th week in group I erythema, pruritus was mild in maximum patients, scaling was absent in maximum patients. At baselie in group II erythema was equally moderate and severe in maximum patients, scaling, pruritus was moderate in maximum patients. At 2nd week in group II erythema was moderate in maximum patients, scaling and pruritus was mild in maximum patients. At 4th week in group I erythema, pruritus was mild in maximum patients, scaling was absent in maximum patients.
Conclusion: The present study concluded that Itraconazole has higher clinical and mycological cure rates as compared to terbinafine. erythema and scaling was absent in more patients in group I than group II.

Keywords

  • Itraconazole
  • Terbinafine
  • Dermatophytosis
  • XML
  • PDF 268.11 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 20
    • PDF Download: 45
European Journal of Molecular & Clinical Medicine
Volume 9, Issue 3
February 2022
Page 1430-1433
Files
  • XML
  • PDF 268.11 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 20
  • PDF Download: 45

APA

Anand, A. S. K. R. M. V. S. (2022). Evaluation of Efficacy of Oral Terbinafine versus Itraconazole in Treatment of Dermatophytic Skin Infections at a Tertiary Care Hospital. European Journal of Molecular & Clinical Medicine, 9(3), 1430-1433.

MLA

Amit Singhal, Kumar Raja Madasu, Vinay Sharma, Anand. "Evaluation of Efficacy of Oral Terbinafine versus Itraconazole in Treatment of Dermatophytic Skin Infections at a Tertiary Care Hospital". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 1430-1433.

HARVARD

Anand, A. S. K. R. M. V. S. (2022). 'Evaluation of Efficacy of Oral Terbinafine versus Itraconazole in Treatment of Dermatophytic Skin Infections at a Tertiary Care Hospital', European Journal of Molecular & Clinical Medicine, 9(3), pp. 1430-1433.

VANCOUVER

Anand, A. S. K. R. M. V. S. Evaluation of Efficacy of Oral Terbinafine versus Itraconazole in Treatment of Dermatophytic Skin Infections at a Tertiary Care Hospital. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 1430-1433.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus